Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Fan

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 14, 2013
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology GroupRobert E Goldsby, Timothy M Fan, Doojduen Villaluna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2016
mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In VivoJames J Morrow, Arnulfo Mendoza, Allyson Koyen, et al.
Investigational New Drugs|December 16, 2016
Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid speciesAlycen P Lundberg, Joshua M Francis, Malgorzata Pajak, et al.
American Journal of Veterinary Research|December 29, 2015
Pharmacokinetics of orally administered low-dose rapamycin in healthy dogsJeanne C Larson, Sara D Allstadt, Timothy M Fan, et al.
Cell Reports|December 15, 2015
A Small Molecule that Induces Intrinsic Pathway Apoptosis with Unparalleled SpeedRahul Palchaudhuri, Michael J Lambrecht, Rachel C Botham, et al.
Oncotarget|November 9, 2017
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patientsAvadhut D Joshi, Rachel C Botham, Lisa J Schlein, et al.
Plos One|July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW FoundationJason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
ACS Central Science|August 31, 2018
Surveillance of Cancer Stem Cell Plasticity Using an Isoform-Selective Fluorescent Probe for Aldehyde Dehydrogenase 1A1Chelsea Anorma, Jamila Hedhli, Thomas E Bearrood, et al.
Investigational New Drugs|May 26, 2010
Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogsPamela W Lucas, Joanna M Schmit, Quinn P Peterson, et al.
Nature Chemical Biology|January 20, 2022
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|May 14, 2013
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology GroupRobert E Goldsby, Timothy M Fan, Doojduen Villaluna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2016
mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In VivoJames J Morrow, Arnulfo Mendoza, Allyson Koyen, et al.
Investigational New Drugs|December 16, 2016
Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid speciesAlycen P Lundberg, Joshua M Francis, Malgorzata Pajak, et al.
American Journal of Veterinary Research|December 29, 2015
Pharmacokinetics of orally administered low-dose rapamycin in healthy dogsJeanne C Larson, Sara D Allstadt, Timothy M Fan, et al.
Cell Reports|December 15, 2015
A Small Molecule that Induces Intrinsic Pathway Apoptosis with Unparalleled SpeedRahul Palchaudhuri, Michael J Lambrecht, Rachel C Botham, et al.
Oncotarget|November 9, 2017
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patientsAvadhut D Joshi, Rachel C Botham, Lisa J Schlein, et al.
Plos One|July 22, 2017
Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW FoundationJason Glover, Tsz-Kwong Man, Donald A Barkauskas, et al.
ACS Central Science|August 31, 2018
Surveillance of Cancer Stem Cell Plasticity Using an Isoform-Selective Fluorescent Probe for Aldehyde Dehydrogenase 1A1Chelsea Anorma, Jamila Hedhli, Thomas E Bearrood, et al.
Investigational New Drugs|May 26, 2010
Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogsPamela W Lucas, Joanna M Schmit, Quinn P Peterson, et al.
Nature Chemical Biology|January 20, 2022
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
Pageof 12